| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 10,649 | 11,727 | 11,867 | 12,282 | | Cost of Revenue | 3,424 | 3,618 | 3,663 | 3,940 | | | Gross Profit |
-
| 8,109 | 8,204 | 8,342 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,601 | 6,687 | 7,059 | 5,829 | | Non Recurring |
-
|
-
|
-
| 4,821 | | Others | 6,210 |
-
| 12,925 | 1,625 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 1,422 | (11,780) | (3,933) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (5,586) | 1,422 | (11,780) | (3,933) | | Interest Expense | 1,014 | 1,098 | 1,045 | 1,362 | | Income Before Tax | (6,600) | 324 | (12,825) | (5,295) | | Income Tax Expense | (2,431) | 118 | (4,720) | (600) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,169) | 206 | (8,105) | (4,695) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,169) | 206 | (8,105) | (4,695) | | Preferred Stock And Other Adjustments | (273) | (483) |
-
|
-
| | | Net Income Applicable To Common Shares | ($4,442) | ($277) | ($8,105) | ($4,695) |
|
0.22% Nasdaq 
Income Statement
